Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. PHGE
PHGE logo

PHGE Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Biomx Inc (PHGE) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Sell
Latest Price
4.110
1 Day change
-8.57%
52 Week Range
14.710
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Biomx Inc (PHGE) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company is facing significant challenges, including leadership instability, poor financial performance, and bearish technical indicators. Additionally, there are no positive trading signals or catalysts to suggest a turnaround in the near term.

Technical Analysis

The technical indicators for PHGE are bearish. The MACD is below 0 and negatively contracting, the RSI is neutral at 32.605, and the moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level (S1: 4.552), with resistance levels at R1: 6.309 and R2: 6.852.

Positive Catalysts

  • NULL identified. There are no significant positive news or trading trends, and no recent signals from Intellectia Proprietary Trading Signals.

Neutral/Negative Catalysts

  • Leadership instability: The resignation of both the CEO and Chairman of the Board raises concerns about the company's direction.

  • Poor financial performance: Net income dropped by -8.10% YoY, EPS declined by -45.86% YoY, and revenue remains stagnant at

  • Analyst downgrade: H.C. Wainwright downgraded the stock to Neutral from Buy, citing concerns about the company's future.

Financial Performance

In Q4 2025, Biomx Inc reported stagnant revenue growth (0% YoY), a net income decline of -8.10% YoY to -$13,337,000, and a significant drop in EPS by -45.86% YoY to -8.18. Gross margin remains at 0%. These metrics indicate a struggling financial position.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

H.C. Wainwright downgraded the stock to Neutral from Buy on March 9, 2026, citing leadership instability and concerns about the company's future.

Wall Street analysts forecast PHGE stock price to rise
1 Analyst Rating
Wall Street analysts forecast PHGE stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 4.490
sliders
Low
26
Averages
26
High
26
Current: 4.490
sliders
Low
26
Averages
26
High
26
H.C. Wainwright
Joseph Pantginis
Buy -> Neutral
downgrade
AI Analysis
2026-03-09
Reason
H.C. Wainwright
Joseph Pantginis
Price Target
AI Analysis
2026-03-09
downgrade
Buy -> Neutral
Reason
H.C. Wainwright analyst Joseph Pantginis downgraded BiomX to Neutral from Buy. BiomX has "had a rough time as of late," says the analyst, who notes that both the CEO and Chairman of the Board resigned from the company on March 6, adding "further concern about the potential path forward for the company."
H.C. Wainwright
Joseph Pantginis
Buy
upgrade
$15 -> $26
2025-11-25
Reason
H.C. Wainwright
Joseph Pantginis
Price Target
$15 -> $26
2025-11-25
upgrade
Buy
Reason
H.C. Wainwright analyst Joseph Pantginis adjusted the firm's price target on BiomX to $26 from $15 and keeps a Buy rating on the shares. The adjusted target follows the company's reverse stock split.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for PHGE
Unlock Now

People Also Watch